Biotech
Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option SEATTLE and VANCOUVER, B.C. , Dec. 7, 2020 /PRNewswire/ — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage more...
Health
Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020
BERWYN, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria more...
Biotech
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020
HACKENSACK, NJ / ACCESSWIRE / December 7, 2020 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative pharmacology, biomarker and data platforms, today announced it more...
Biotech
Curis Announces Updated Preliminary Data from Ongoing Phase 1 Study of CA-4948 Showing Durable and Dose-Dependent Reductions in Tumor Burden in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
Curis Announces Updated Preliminary Data from Ongoing Phase 1 Study of CA-4948 Showing Durable and Dose-Dependent Reductions in Tumor Burden in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma LEXINGTON, Mass. , Dec. 7, 2020 /PRNewswire/ more...
Health
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California–(Newsfile Corp. – December 7, 2020) – The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Evolus, Inc. (NASDAQ: EOLS) (“Evolus” or “the Company”) for violations more...
Biotech
Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma
AFM13 monotherapy was well tolerated and reached an Objective Response Rate of 42 percent among heavily pretreated patients with R/R CD30-positive lymphoma with cutaneous presentation Immunological analyses revealed that innate cell engagers modulate NK and more...
Biotech
FDA Approves Label Expannsion of Novo Nordisk’s (NVO) Saxenda
Novo Nordisk A/S ( NVO ) announced that the FDA has approved an updated label for Saxenda (liraglutide) injection 3 mg. The Saxenda Injection is now approved for the treatment of obesity in adolescents (12-17 years) more...
Cannabis
PURA and ALKM To Reveal New Hemp Derived CBD Infused Product Lines Thursday December 10th
PURA and ALKM To Reveal New Hemp Derived CBD Infused Product Lines Thursday December 10th DALLAS , Dec. 7, 2020 /PRNewswire/ — Puration, Inc. (USOTC: PURA) and Alkame Holdings Inc. (USOTC: ALKM) today announced plans to more...
Cannabis
WeedMD Debuts New Color Cannabis Cultivar Black Sugar Rose in Ontario and Launches Terpene-Labelled Profiles
Acclaimed strain release d via the Ontario Cannabis Store with other provinces coming soon T erpene -l abelling affirms Company’s pledge to consumer education and product integrity TORONTO, Dec. 07, 2020 (GLOBE NEWSWIRE) — WeedMD more...
Energy
Ocean Power Technologies Taps SeaTrepid International for First Remote OPT PowerBuoy® Deployment
Turnkey Installation of OPT PowerBuoy® Solution in Chile MONROE TOWNSHIP, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NASDAQ: OPTT), a leader in innovative and cost-effective ocean energy solutions, more...